Intuitive Surgical (ISRG) EBITDA (2009 - 2026)

Intuitive Surgical has reported EBITDA for 18 years, with the latest figure at $799.7 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 10.67% year-over-year to $799.7 million; the trailing twelve-month figure through Mar 2026 stood at $3.1 billion (up 20.05% YoY), and the FY2025 full-year result was $2.9 billion, up 25.4% from the prior year.
• EBITDA for Q1 2026 stood at $799.7 million, down from $864.3 million in the prior quarter.
• The five-year high for EBITDA was $864.3 million in Q4 2025, with the low at $279.1 million in Q2 2022.
• Average EBITDA over 5 years is $539.7 million, with a median of $512.1 million recorded in 2024.
• Year-over-year, EBITDA plunged 46.47% in 2022 and soared 63.24% in 2024.
• Tracing ISRG's EBITDA over 5 years: stood at $372.5 million in 2022, then grew by 20.86% to $450.2 million in 2023, then jumped by 63.24% to $734.9 million in 2024, then gained by 17.61% to $864.3 million in 2025, then retreated by 7.47% to $799.7 million in 2026.
• The last three EBITDA figures came in at $799.7 million (Q1 2026), $864.3 million (Q4 2025), and $727.9 million (Q3 2025), per Business Quant data.

Peer Comparison